New Capabilities Added to the Site in the USA by Evonik Industries

Font size AAA
20 Nov 2013 09:21 Helen Clark

CHEMMONITOR.COM - Germany-based industrial corporation Evonik Industries added API (HPAI) capabilities of high potency for formulation development and clinical supply of oral and parenteral drugs.

The facilities at Birmingham site in Alabama can handle HPAIs with OELs to about 0.1 microgram per cubic meter.

03 Feb
Arlanxeo to Start Chloroprene Rubber Capacity Expansion in Q2 2018
03 Feb
Nippon Shokubai to Raise Production Capacities at Three Plants
03 Feb
Grupo Antolín Irausa to Build Three New Plants in the USA
26 Jan
SK Global Chemical Shuts No. 2 Naphtha Cracker in Ulsan
26 Jan
Perlen Packaging to Purchase Stake in Sekoya Indústria e Comércio